Peripartum cardiomyopathy

  title={Peripartum cardiomyopathy},
  author={S. Murali and M. Baldisseri},
  journal={Critical Care Medicine},
Objective:To provide a review of the cardiac and obstetrical literature regarding the development of peripartum cardiomyopathy and, in particular, to examine risk factors, incidence, diagnosis, prognosis, and evidence-based treatment modalities. Design:An extensive review of the current literature. Results:Peripartum cardiomyopathy is a cardiomyopathy of unknown cause that occurs in pregnant females, most commonly in the early postpartum period. It shares many clinical characteristics with… Expand
Peripartum Cardiomyopathy
Peripartum cardiomyopathy (PPCM) is a rare form of unexplained cardiac failure of unknown origin, unique to the pregnant woman with highly variable outcome associated with high morbidity andExpand
Peripartum cardiomyopathy — still unknown. Current state of knowledge
Peripartum cardiomyopathy (PPCM) is defined as idiopathic cardiomyopathy which occurs at the end of pregnancy or in the first few months after delivery, with symptoms of heart failure (HF) secondaryExpand
Left Hemiplegia: An Unusual Presentation of Peripartum Cardiomyopathy (PPCM)
An unusual case of PPCM is reported in a previously healthy woman who presented with features of heart failure and left hemiplegia due to thromboembolism, which suggests an autoimmune cause rather than the pregnancy exacerbating a pre-existing cardiomyopathy. Expand
Coexistence of postpartum cardiomyopathy and single coronary artery anomaly
In this case study, coronary angiography was used to determine the etiology of the cardiomyopathy after the decompensated heart failure had regressed, and a congenital single coronary artery anomaly was detected by coronaryAngiography. Expand
Akut Hepatit Nedeniyle Tanı Konulan Peripartum Kardiyomyopati
Ischemic hepatitis is one of the treatable causes of acute liver injury and must always be included in the differential diagnosis of acute hepatitis with unknown pathogenesis. Expand
Management of pregnant women with cardiac diseases at potential risk of thromboembolism--experience and review.
  • F. Cho
  • Medicine
  • International journal of cardiology
  • 2009
Prenatal correction of the underlying cardiac malformation, precise switch of anticoagulant administration, optimizing cardiac function, early delivery prior to heart failure, postpartum fluid restriction, minimized peripartum blood loss, and meticulously intensive cares are essential to achieve satisfactory outcomes. Expand
Kardiomiopatia połogowa — wciąż niepoznana. Aktualny stan wiedzy
The clinical course of PPCM varies from life-threatening acute heart failure to mild symptoms mimicking the symptoms typical of the perinatal period, and the inclusion of bromocriptine in PPCm therapy seems to be justified, and in some cases improves the prognosis. Expand
Peripartum Cardiomyopathy: Do Exosomes Play a Role?
This life-threatening condition is relatively uncommon, but the incidence has been climbing up, and because of its high mortality, it is crucial for physicians to have high suspicious for the disease. Expand
Critical Illness in Pregnancy: Part II: Common Medical Conditions Complicating Pregnancy and Puerperium.
Pregnancy-specific adjustments in the management of obstetric disorders, including vaginal tract infections unique to pregnancy, and common neurologic problems in pregnancy include seizures, altered mental status, visual symptoms, and strokes are reviewed. Expand
Acute respiratory distress syndrome with transiently impaired left ventricular function and Torsades de Pointes arrhythmia unmasking congenital long QT syndrome in a 25-yr-old woman.
We report a case of recurrent episodes of Torsades de Pointes arrhythmia in the setting of transiently impaired left ventricular ejection fraction, acute respiratory distress syndrome, transientExpand


Peripartum cardiomyopathy: Current therapeutic perspectives
Patients with peripartum cardiomyopathy are diagnosed by clinical evaluation and echocardiography, and a standard heart failure medical regimen should be instituted, with significant improvement in ventricular function can be expected in up to 50% of patients. Expand
Peripartum cardiomyopathy: an ominous diagnosis.
The unique hemodynamic stresses of pregnancy unmask previously undiagnosed cardiomyopathy in otherwise medically stable individuals and the prognosis for these patients is guarded. Expand
Incidence of myocarditis in peripartum cardiomyopathy.
A retrospective review of endomyocardial biopsy specimens from 34 patients fulfilling the criteria for a diagnosis of PC showed a lower incidence of myocarditis than that reported in other studies, and factors that may influence the diverse range in the reported incidence are discussed. Expand
Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics.
Seven (50%) of the patients with peripartum cardiomyopathy had dramatic improvement within 6 weeks of follow-up, and 6 (43%) died, and there was no difference in ventricular arrhythmia, left ventricular chamber size, ejection fraction or hemodynamics. Expand
A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography.
A modified pharmacologic echocardiographic stress test is described that might be useful in determining left ventricular contractile reserve in women believed to be recovered by routine echOCardiographic studies, and the data may be useful when counseling women on future childbearing. Expand
Peripartum myocarditis and cardiomyopathy.
In patients with peripartum cardiomyopathy, the etiology remains unclear although myocarditis was present in 78% of those with this condition, and resolution of mycarditis is associated with significant improvement in left ventricular function. Expand
Improved outcomes in peripartum cardiomyopathy with contemporary.
The morbidity related to PPCM is less than previously reported and initial LV end-diastolic dimension and EF at 2 months predict long-term outcomes, while the withdrawal of heart failure medications after recovery did not lead to decompensation. Expand
Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1.
Cytokine and sFas levels are elevated in patients with PPC, and despite treatment with ACE inhibitors and beta-blockers, mortality remains high, however, in 34% of the patients, left ventricular function almost completely normalized. Expand
Intravenous immune globulin in the therapy of peripartum cardiomyopathy.
In this small retrospective study of women with peripartum cardiomyopathy, patients treated with immune globulin had a greater improvement in ejection fraction during early follow-up than patients treated conventionally. Expand
Peripartum Cardiomyopathy: Experiences at King Edward VIII Hospital, Durban, South Africa and a Review of the Literature
A high incidence of PP-CMO in the local African population (1: 1000 deliveries), and a high complication rate (35%): it suggests that early diagnosis and appropriate therapy may avert an adverse outcome. Expand